Background Chronic kidney disease and anemia often coexist and may accompany
diabetes; all 3 conditions are associated with worse cardiovascular outcomes. This study …

The evidence for the impact of renal dysfunction in patients with diabetes mellitus (DM) and
first cardiovascular diseases on mid-term adverse outcomes remain scarce. This study …

Background—The optimal approach to revascularization in patients with kidney disease has
not been determined. We studied survival by treatment group (CABG, percutaneous …

Chronic kidney disease (CKD) is associated with a high burden of coronary artery disease
(CAD), which remains the most common cause of morbidity and mortality in CKD patients …

C hronic kidney disease (CKD) is ubiquitous in the world and may eventually progress to
end‐stage renal disease. CKD is associated with a greater risk of coronary artery disease …

Chronic kidney disease (CKD) is associated with a high burden of coronary artery disease,
myocardial infarction and cardiovascular death. Detection and treatment of coronary artery …

Background and Objectives Chronic kidney disease (CKD) is known to be a major adverse
predictor in diabetes mellitus (DM) patients undergoing percutaneous coronary intervention …

Background—The effects of diabetes on short-term results of coronary artery bypass graft
(CABG) surgery are known, but less is known about the long-term effects of diabetes and …

Objective Chronic kidney disease is a known risk factor in cardiovascular disease, but its
influence on treatment effect of bypass surgery remains unclear. We assessed the influence …

The optimal coronary revascularization strategy (coronary artery bypass grafting [CABG] or
percutaneous coronary intervention [PCI]) in patients with end-stage renal disease (ESRD) …